Galena to receive EU patent for breast-cancer vaccine

The European Patent Office notifies Galena Biopharma (GALE +7.6%) that it intends to grant a patent that covers the use of the company's NeuVax drug as a vaccine for the prevention of relapse in breast-cancer patients.

The patent is due to expire in April 2028. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs